Core Viewpoint - Jefferies upgraded Insulet Corporation's stock to a "Buy" rating with a new price target of $400, reflecting confidence in the company's growth potential driven by its innovative products [1][6] Financial Performance - Insulet reported earnings per share of $1.24 for Q3 2025, exceeding the Zacks Consensus Estimate of $1.13, marking a 9.73% earnings surprise and a significant increase from $0.90 per share in the same period last year [2][6] - The company's revenue for the quarter reached $706.3 million, surpassing the Zacks Consensus Estimate by 4.42% and showing a substantial increase from $543.9 million in the same quarter the previous year [3][6] Market Reaction - Following the announcement, Insulet's stock price increased by 2.85%, or $8.96, with fluctuations between a low of $290.16 and a high of $335 during the trading day [4] - Over the past year, the stock has seen a high of $353.50 and a low of $230.05, with a current market capitalization of approximately $22.76 billion [4] Strategic Insights - The earnings call provided insights into Insulet's strategic direction, highlighting the company's strong performance and positive outlook, which have contributed to the stock's upward momentum [5]
Jefferies Upgrades Insulet Corporation (NASDAQ:PODD) to "Buy"